Product Category

Azarest Azacitidine 300 mg Tablet

Azarest Azacitidine 300 mg Tablet is an effective antineoplastic agent used primarily in the treatment of myelodysplastic syndromes (MDS), a group of disorders caused by poorly formed or dysfunctional blood cells. Azacitidine works by inhibiting DNA methylation, which can help restore normal function to bone marrow and improve blood cell production. It can also be used to treat certain types of leukemia, including acute myeloid leukemia (AML). Our super specialty pharmacy provides high-quality Azarest with personalized treatment plans and expert support to ensure optimal care for patients with MDS and leukemia. Trust us for comprehensive and effective cancer care tailored to your needs.

₱25,000 ₱24,750

Alkixen Crizotinib 250 mg Capsules

Alkixen Crizotinib 250 mg Capsules is a prescription medication used in the treatment of certain types of cancer. Crizotinib is a tyrosine kinase inhibitor that works by blocking abnormal proteins produced by some genes. These proteins can promote the growth of cancer cells.

Indications:

Alkixen is indicated for the treatment of:

• Non-small cell lung cancer (NSCLC) that is ALK-positive
• ROS1-positive metastatic NSCLC

How to Use:

• Take Alkixen exactly as prescribed by your healthcare provider.
• Swallow the capsule whole with a full glass of water.
• Do not crush, chew, or break the capsule.
• It can be taken with or without food.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Alkixen may include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Fatigue
• Edema (swelling)
• Vision problems (blurred vision, light sensitivity)
• Liver enzyme abnormalities

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring of liver function tests and heart function (ECG) may be required during treatment.
• Use effective contraception to avoid pregnancy while taking Alkixen, as it may harm an unborn baby.
• Alkixen is not recommended for use in breastfeeding women.

Storage:

• Store Alkixen capsules at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the capsules in their original container, tightly closed and protected from light.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

₱0

Alecnib Alectinib 150 mg Capsules

Alecnib (Alectinib 150 mg Capsules) is a prescription medication used for the treatment of specific types of lung cancer. Alectinib is a tyrosine kinase inhibitor that targets and blocks the activity of anaplastic lymphoma kinase (ALK), a protein that contributes to the growth and spread of cancer cells.

Indications:

Alecnib is indicated for the treatment of:

• ALK-positive, metastatic non-small cell lung cancer (NSCLC)

How to Use:

• Take Alecnib exactly as prescribed by your healthcare provider.
• Swallow the capsule whole with a full glass of water.
• Do not crush, chew, or break the capsule.
• It should be taken with food to improve absorption.
• Follow your doctor's instructions regarding the dosage and duration of treatment.

Side Effects:

Common side effects of Alecnib may include:

• Fatigue
• Constipation
• Edema (swelling) in hands and feet
• Myalgia (muscle pain)
• Cough
• Rash
• Increased liver enzymes

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring of liver function and creatine phosphokinase (CPK) levels is recommended during treatment.
• Use effective contraception to avoid pregnancy while taking Alecnib, as it may harm an unborn baby.
• Alecnib is not recommended for use in breastfeeding women.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.

₱0

Caboxen Cabozantinib 20 mg Capsules

Caboxen Cabozantinib 20 mg Capsules are a breakthrough medication meticulously engineered to combat specific types of advanced cancers. Each capsules contains 20 mg of cabozantinib, a potent inhibitor targeting key pathways involved in tumor growth and angiogenesis.

Mode of Action: Cabozantinib, the active ingredient in Caboxen Cabozantinib 20 mg capsules, inhibits multiple receptor tyrosine kinases involved in tumor cell proliferation, angiogenesis, and metastasis. By blocking these signaling pathways, cabozantinib helps suppress tumor growth and spread.

Indications: Caboxen Cabozantinib 20 mg capsules are indicated for the treatment of:

• Advanced Renal Cell Carcinoma (Kidney Cancer)
• Hepatocellular Carcinoma (Liver Cancer)
• Medullary Thyroid Cancer

Dosage and Administration: The recommended dosage of Caboxen Cabozantinib 20 mg is one capsules (20 mg) to be taken orally once daily. Dosage adjustments may be necessary based on individual patient factors and tolerance. capsules can be taken with or without food, but consistency in administration is crucial.

Precautions:

• Prior to initiating treatment with Caboxen Cabozantinib 20 mg capsules, patients should undergo thorough medical evaluation, including assessment of cardiac function and blood pressure.
• Close monitoring of blood pressure, liver function, and thyroid function is essential during therapy.
• Patients should avoid consuming grapefruit or grapefruit juice while taking Caboxen Cabozantinib 20 mg capsules, as it may increase drug levels in the bloodstream.

Side Effects: Common side effects associated with Caboxen Cabozantinib 20 mg capsules may include:

• Fatigue
• Diarrhea
• Nausea
• Decreased appetite
• High blood pressure
• Palmar-plantar erythrodysesthesia (hand-foot syndrome)
• Weight loss
• Changes in taste

₱45,000 ₱40,000

Acabrunat Acalabrutinib 100mg Capsules

Experience cutting-edge treatment for blood cancers with Acabrunat Acalabrutinib 100mg Capsules. Each capsule contains 100mg of acalabrutinib, a potent inhibitor targeting cancerous B-cells' growth and survival. Harnessing the power of science, Acabrunat offers hope for patients battling Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL).

Benefits:

• Targeted Therapy: Acalabrutinib selectively inhibits Bruton tyrosine kinase (BTK), halting cancer cell proliferation while sparing healthy cells.
• Enhanced Efficacy: By blocking BTK signaling pathways, Acabrunat promotes apoptosis, delivering potent anti-cancer effects.
• Improved Quality of Life: With Acabrunat, patients can experience reduced symptoms and enhanced overall well-being.

Dosage and Administration: Take one Acabrunat Acalabrutinib 100mg Capsule orally, once daily, or as directed by your healthcare professional. Swallow the capsule whole with a glass of water, with or without food.

Precautions:

• Follow your healthcare provider's instructions strictly for optimal treatment outcomes.
• Inform your doctor about all medications, supplements, and medical conditions before starting Acabrunat.
• Regular check-ups and monitoring are essential during treatment to assess response and manage potential side effects.

Side Effects: Common side effects may include:

• Nausea
• Diarrhea
• Headache
• Fatigue
• Respiratory infections

₱80,000 ₱74,250

Tucaxen Tucatinib 150 mg Tablet

TABLE OF CONTENT
Mode of Action
Indications
Dosage and Administration
Precautions
Side Effects

Tucaxen Tucatinib 150 mg Tablet is a cutting-edge medication meticulously engineered to target specific proteins involved in the growth and spread of cancer cells. Each tablet contains 150 mg of tucatinib, a potent tyrosine kinase inhibitor renowned for its efficacy in treating certain types of advanced or metastatic cancers.

Mode of Action: Tucatinib, the active ingredient in Tucaxen Tucatinib 150 mg Tablet, selectively inhibits the activity of human epidermal growth factor receptor 2 (HER2) and tyrosine kinase, key drivers of cancer cell proliferation and survival. By disrupting these signaling pathways, tucatinib helps suppress tumor growth and metastasis.

Indications: Tucaxen Tucatinib 150 mg Tablet is indicated for the treatment of:

• HER2-Positive Metastatic Breast Cancer
• HER2-Positive Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

Dosage and Administration: The recommended dosage of Tucaxen Tucatinib 150 mg Tablet is one tablet (150 mg) to be taken orally twice daily with or without food. The dosage may vary based on individual patient factors and concurrent treatments. Patients should adhere strictly to the prescribed regimen provided by a healthcare professional.

Precautions:

• Prior to initiating treatment with Tucaxen Tucatinib 150 mg Tablet, patients should undergo thorough medical evaluation, including assessment of cardiac function and liver enzymes.
• Close monitoring of cardiac function, liver function, and gastrointestinal symptoms is essential during therapy.
• Tucatinib may interact with certain medications, so patients should inform their healthcare provider about all concurrent medications, including over-the-counter drugs and herbal supplements.

Side Effects: Common side effects associated with Tucaxen Tucatinib 150 mg Tablet may include:

• Diarrhea
• Nausea
• Fatigue
• Vomiting
• Elevated liver enzymes
• Decreased appetite
• Hand-foot syndrome (palmar-plantar erythrodysesthesia)

₱120,000 ₱108,000

MabAll Rituximab 500mg Vail

MabAll Rituximab 500mg Vial is a powerful medication designed to target specific cells in the body involved in the immune response. Each vial contains 500mg of rituximab, a monoclonal antibody that selectively targets CD20-positive B-cells, which are often implicated in certain types of cancers and autoimmune diseases.

Mode of Action: Rituximab, the active ingredient in MabAll Rituximab 500mg Vial, works by binding to CD20 antigen present on the surface of B-cells. This binding triggers various immune mechanisms, including antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity, leading to the destruction of targeted B-cells. By depleting these abnormal B-cells, rituximab helps modulate the immune response and combat diseases.

Indications: MabAll Rituximab 500mg Vial is indicated for the treatment of:

• Non-Hodgkin's Lymphoma
• Chronic Lymphocytic Leukemia
• Rheumatoid Arthritis
• Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
• Microscopic Polyangiitis

Dosage and Administration: The recommended dosage of MabAll Rituximab 500mg Vial varies depending on the specific condition being treated, the patient's weight, and other factors. It is typically administered intravenously by a healthcare professional over a specified period. Dosage and administration should be tailored to the individual patient's needs and medical history.

Precautions:

• Prior to initiating treatment with MabAll Rituximab 500mg Vial, patients should undergo thorough medical evaluation, including screening for hepatitis B virus (HBV) infection.
• Close monitoring for signs of infusion reactions, infections, and other adverse effects is essential during and after rituximab therapy.
• Patients should receive appropriate premedication to reduce the risk of infusion-related reactions.
• Rituximab should be used with caution in patients with a history of cardiac or pulmonary conditions.

Side Effects: Common side effects associated with MabAll Rituximab 500mg Vial may include:

• Infusion reactions (fever, chills, nausea, headache, rash)
• Fatigue
• Infections (upper respiratory tract infections, urinary tract infections)
• Low white blood cell count (neutropenia)
• Low platelet count (thrombocytopenia)
• Hypertension (high blood pressure)

₱18,000 ₱15,000

Cazanat Cabozantinib 60mg Tablet

Cazanat Cabozantinib 60mg Tablet is a potent medication specifically formulated to combat certain types of advanced cancer. Each tablet contains 60mg of cabozantinib, a targeted therapy known for its efficacy in treating renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer.

₱40,000 ₱37,000